Objective: Acute gastroenteritis is an important cause of morbidity and mortality in developing countries. Children under 5 years of age are more commonly affected, while 80% of deaths occur in children under 2 years of age. Escherichia coli, Salmonella spp., and Shigella spp. are the most common causative bacterial pathogens. Since the summer of 2014, a large number of Salmonella and Shigella gastroenteritis cases have occurred in our region, which is considered as a small local outbreak. We aim to report the features and antibiotic susceptibility of microorganism isolates obtained during this epidemic. Material and Methods: Between July and September 2014, patients who were admitted to pediatric clinics and emergency services on account of acute gastroenteritis lasted less than 15 days were included in this retrospective study. Stool microscopy, stool cultures, and blood cultures were performed. Salmonella and Shigella strains were subjected to antimicrobial susceptibility testing. Results: A total of 2425 patients were admitted because of acute gastroenteritis during the study period. Salmonella spp. and Shigella spp. were isolated in 113 children. The mean age of the children was 91.5±60.3 months (4-213 months). Of the 113 patients, 56% were male and 44% were female. Shigella spp. were found in 77 patients (3.2%), and Salmonella spp. were found in 36 patients (1.5%). Salmonella enteritidis was detected in 29 patients (80.5%), whereas Salmonella typhimurium was detected in 3 patients (8.3%). In addition, Shigella sonnei was identified in 63 patients (81.8%) and Shigella flexneri in 8 patients (10.3%). In contrast to ceftriaxone susceptibility in Salmonella strains, 9.1% of Shigella strains were found to be resistant to ceftriaxone. Ciprofloxacin resistance was found in 5.6% and 1.3% strains of Salmonella and Shigella spp. respectively. Although the ampicillin resistance values of 2 strains were close, trimethoprim-sulfamethoxazole (TMP) resistance was found in 89.6% Shigella strains. Conclusion: Salmonella and Shigella are common bacterial pathogens. Resistance patterns must be known to select the most effective treatment. According to our study, ceftriaxone and ciprofloxacin appear to be the first choice of empirical treatment for acute bacterial gastroenteritis. Additionally, if the resistance states of ampicillin and TMP are known, these drugs can also be used as empirical treatment. (J Pediatr Inf 2015; 9: 102-7) 
Introduction
Acute gastroenteritis is an important cause of morbidity and mortality for children especially in developing countries. It is known that nearly four million children die annually in these countries (1) . While children under five years of age are more commonly affected, 80% of deaths occur in children under two years of age (2) . Acute gastroenteritis cases are mostly infectionrelated. Bacteria, viruses and parasites are the gastroenteritis pathogens (3) . Escherichia coli, Salmonella spp. and Shigella spp. are most prevalent bacterial pathogens causing gastroenteritis. Salmonella and Shigella are the significant causes of acute gastroenteritis (4) . Infection occurs through the oral intake of contaminated water and foods. Furthermore, hygiene conditions and insufficiencies in sanitation implementations also pave the way for acute gastroenteritis. Although clinical recovery is enabled through rehydration treatment in acute gastroenteritis cases except the invasive diseases, antibiotic treatment is also significant in some special instances. However, today antimicrobial resistance has turned into an important health problem. Therefore, it is beneficial for the health services to know gastroenteritis pathogens and antimicrobial susceptibility (5) . In the period that started with the summer of 2014, many more Salmonella and Shigella gastroenteritis cases than normal season have occurred in our service area. The sudden increase in the number of cases has shown that there is a local epidemic. In this study we aimed to report the features of the isolates obtained and their antibiotic susceptibility; and to compare the isolates obtained in previous studies and their antibiotic susceptibility.
Material and Methods
Patients aged 0-18 years who were admitted to pediatric clinics and emergency services due to the diagnosis of acute gastroenteritis with story of shorter than 15 days and were followed up with an early diagnosis of acute gastroenteritis on outpatient or inpatient basis Between July and September 2014, were investigated retrospectively. Following the microscopic examination of the patients' stools upon their admittance, MacConkey agar and Salmonella Shigella (SS) agar were planted on sheep blood agar through lobed metal loops. Plates were incubated for 24 hours in an incubator. The colonies that were lactose negative in the medium were examined with the early diagnosis of Salmonella and Shigella. For this purpose, (1) TSI medium (Triple Sugar Iron) (three-sugared iron agar), (2) LIA medium (Lysine Iron Agar) (lysine-iron agar), (3) Crystensen ure agar medium, (4) Simon's sitrat agar medium, (5) MIO (motility-indol-ornithine) movement mediums were used. Mediums were incubated for 18 hours in the incubators and afterwards were evaluated for biochemical definition. The colonies thought to be salmonella were applied the Salmonella polyvalent-O-antiserum and were spared for type determination when agglutination grew. Type determination in Salmonella strains was done with the automatized Phoenix (Becton Dickinson, New Jersey, ABD) device. The colonies suspected to have Shigella were removed from TSI medium and suspended on a lamina. They were compared with antiserums and those giving out agglutination were defined as Shigella. Type determination was done by using the antiserums to be used for S. sonnei and S. flexneri. Sufficient amount of blood samples were planted on the BACTEC medium for culture. The strains diagnosed with Salmonella and Shigellatype bacteria were subjected to antimicrobial susceptibility test via the Kirby -Bauer disk diffusion method. Susceptibility was investigated by Ampicillin (10 µg), chloramphenicol (30 µg), tetracycline (30 µg), streptomycin (10 µg), TMP (25 µg), ciprofloxacin (5 µg), cefixime (15 µg), ceftriaxone (30 µg) disks. The zones around the disks were measured and grouped as susceptible and resistant according to the CLSI (Clinical and Laboratory Standards Institute) chart. Stool microscopy, stool culture, antimicrobial susceptibility test results and clinic information of the patients were obtained from the record files. Data of the patients were evaluated with the SPSS program.
Results
A total of 2425 patients were admitted because of acute gastroenteritis. Given the Salmonella spp. and Shigella spp. growth in the stool and blood cultures of children in their clinic information, a total of 113 children were included in the study. Children were aged 91.5±60.3 months (4-213 months). Of the 113 patients, 56% were male and 44% were female. While 17 children (15.1%) were two years old and below, eight children were one year old (7.1%) or younger. While culture growth was detected in 96.5% of the stools, they were found 3.5% in blood. Four patients who had growth in their blood did not have any growth in their stool culture. When the pathogens were examined, it was found that Shigella spp. grew in 77 (3.2%) patients and Salmonella spp. in 36 (1.5%) patients. 16 of the children (44%) in whom Salmonella grew, were female and 20 (56%) male. Regarding Salmonella infections that were subjected to typing, in 29 patients (80.5%), S. enteritis was the pathogen and in 3 patients (8.3%) S. typhimurium was the pathogen. No typing was done for the remaining four (11.2%) strains. Regarding Shigella infections that were subjected to typing, it was found that in 63 patients (81.1%) and S. sonnei was the pathogen, in 8 patients (10.3%), S. flexneri was the pathogen; and no typing was done for the remaining six (7.8%%) strains. Table I  and Table II illustrate the antibiotic resistance in Salmonella and Shigella gastroenteritis.
When the resistance of Salmonella strains were compared in relation to serogroups, while the resistance of S. typhimurium to ampicillin (p=0.004), chloramphenicol (p=0.006), ciprofloxacin (p=0.006), tetracycline (p=0.017) and trimethoprim-sulfamethoxazole (TMP) (p=0.002) was statistically more significant than S. enteritis, no significant difference was found between the two strains in the resistance of streptomycin (p=0.501). When the antibiotic resistance of Shigella strains were compared in relation to serogroups, while TMP resistance (p=0.004) of S. sonnei was statistically higher than S. flexneri, no difference was found between the resistances of ampicillin (p=0.072), cefixime (p=1.00), ceftriaxone (p=0.538), streptomycin (p=0.722) and tetracycline (p=0.097).
Discussion
Acute gastroenteritis is one of the most prevalent childhood diseases. Salmonella and Shigella are the bacterial gastroenteritis pathogens causing significant morbidity and mortality. These infections cause clinical and epidemiological problems especially in developing countries (6) . Salmonella may cause enteric fever, gastroenteritis, bacteremia, local infections and different clinical conditions such as asymptomatic carriage. Except some special circumstances, it usually generates a self-limiting disease table. It has been reported that annually 1,4 million Salmonella infection is seen in the United States, 15,000 of those cases are hospitalized and nearly 400 cases result in mortality (7). 3.3-8.4% Salmonella spp. was efficiently isolated from the samples from the pediatric patients who were admitted to the hospitals due to gastroenteritis in our country (8, 9) . Salmonella typhimurium and S. enteritis are the most prevalently isolated types in our country as well as in the world. When the Salmonella strains are examined in the studies carried out, it is seen that the following were found as the pathogens: Keşli et al. (8) Shigella is also another pathogen of bacterial gastroenteritis. It may cause clinic conditions such as nausea, vomiting, watery diarrhea and bloody diarrhea. Shigella gastroenteritis is seen in 165 million cases all over the world. Furthermore, it causes mortality in one million cases (11) . In our country, Shigella spp. has been shown 3.2-15.6% to be the pathogen in the samples taken from the patients admitted due to pediatric gastroenteritis cases (8, 9) . In the United States, the most prevalent pathogens were S. sonnei (>75%) followed by S. flexneri (12) . There have been some regional differences in our country; while S. flexneri was the most prevalently isolated type in 1990s, S. sonnei has recently been reported to have a higher rate in comparison to other types (9) . In previous studies, the following were found as the pathogens: Altun et al. (13) S. sonnei 87% and S. flexneri 11.4%, Gülmez et al. (9) S. sonnei 55.6% and S. flexneri 33.3%. In our study, we found that S. sonnei was 81.8% and S. flexneri 10.3%.
Today, antimicrobial resistance is an important problem. It was reported that some Salmonella and Shigella strains were resistant to chloramphenicol, ampicillin, TMP and sulfonamides. This particular result required the use of antimicrobial agents such as fluoroquinons and third generation cephalosporin which were controversial (14) . Full resistance of Salmonella typhi and S. paratyphi to fluoroquiadones is not now prevalently seen, it has been increasing all over the world. It was reported in India, Korea and Nepal that Full resistance to fluoroquiadones rose from 0% to 13% (15) . It was found that while ciprofloxacin resistance of S. typhi and S. paratyphi A in Nepal between 1998-2002 was 1.6% and 3.9% respectively, it rose to 10.6% and 14.3% between 2008-2011 (16) . In the studies done in our country, it has been revealed that ampicillin resistance was the most prevalent in Salmonella strains. Table III illustrates the studies done in Turkey (8, 9, (17) (18) (19) (20) .
Antibiotic susceptibility tests play a crucial role in the management of Shigella infections. In many geographic regions today, increased antibiotic resistance has been reported (21) . In the United States, nearly 35% ampicillin and 67% TMP resistance is seen (15) . According to the 2011 data of the National Antimicrobial Resistance Monitoring System, while 97% resistance was detected for ceftriaxone, azithromycin and ciprofloxacin, 34% ampicillin and 67% TMP resistance was found (15) . The resistance pattern of the Shigella strains found in the studies done Table IV (8, 9, 13, (22) (23) (24) . It is seen that the highest one was ampicillin and TMP resistance.
In the study carried out in 2001 by İnce et al. from our clinic, it was found that in Salmonella gastroenteritis S. enteritidis was 68.2 %, S. typhimurium 17.1% and S. paratyphi B 7.3%; in Shigella gastroenteritis, 92.4% S. sonnei and 7.6 % S. flexneri were the pathogens (25) . In our study, it was found that in Salmonella strains, 80,5% S. enteritis and 8.3% S. typhimurium and in Shigella strains 81.8% S. sonnei and 10.3% S. flexneri were the pathogens. The antibiotic resistance found in the two studies done in our clinic is illustrated in Table 5 (25) . While no ciprofloxacin resistance was seen in the Salmonella strains in 2001, a new developing resistance was found in our study. The fact that no ceftriaxone resistance was found in both studies supports the view that ceftriaxone could be used as the first option in the empirical treatment of Salmonella gastroenteritis; and in addition, ampicillin and TMP treatments could be given if the resistance status was known. In Shigella gastroenteritis, on the other hand, it was revealed from the results obtained that ceftriaxone and ciprofloxacin could be used in the empirical treatment; and in addition, ampicillin and TMP treatments could be given if the resistance status was known. Furthermore, the increased ceftriaxone resistance in the Shigella strains is noticeable.
Although antimicrobial susceptibility among the Shigella types is different, this difference may vary from region to region depending on the empirical antibiotics.
Their ability to develop resistance to Ampisilin, TMP and nalidixic acid has restricted their use in empirical treatment in dysentery (26) . Instead of these drugs, ceftriaxone, azithromycin and ciprofloxacin are used in empirical treatment. However, it has been reported recently that resistance has increasingly been developing against these groups of drugs especially in Asia (27) . When compared with the third generation ciprofloxacin resistance in Shigella types seen in Europe-Amerika and Asia-Africa between 1998-2012, it was revealed that the resistance in Asia-Africa was higher. Ceftriaxone, cefotaxime and ceftazidime resistance gradually increased between 2010-2012, it was found 14.2%, 22.6% and 6.2% respectively. However, these rates in Europe and America in the last 15 years have been less than 1%. Increased resistance has been reported especially for S. sonnei (28) .
Shigella types carrying SHV, TEM, CTX-M type extended spectrum beta-lactamase (ESBL) enzymes have been reported. Furthermore, bacteria inclusive of OXA, AmpC and metallo-beta-lactamase have been defined and they are claimed to be responsible for the resistance of ceftriaxone (29) . In the studies done in our country, the rate of 3.6-9.5% third generation cephalosporin resistance was found in Shigella types (8, 13) . In our study, we found 9.1% ceftriaxone resistance in Shigella strains and also observed that this rate increased over time. The emerging result constitutes a significant risk for the likely bacteria in the future due to the transfer of especially the resistant gens amongst the bacteria. 
Conclusion
Salmonella and Shigella are the prevalent bacterial pathogens and it is important to know the resistance patterns in order to implement their therapies efficiently. It will be enlightening to determine the local resistance status and know the changing resistance patterns. Consequently, antibiotic appropriate with the antibiogram of the patient should be given without any generalization in the treatment; thus, efficient treatment will have been ensured. In our study, it was revealed that in the treatment of acute bacterial gastroenteritis, TMP and ampicillin were no longer the first choice in treatment and instead ceftriaxone and ciprofloxacin could be used.
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